1. Home
  2. SYK vs BMY Comparison

SYK vs BMY Comparison

Compare SYK & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stryker Corporation

SYK

Stryker Corporation

HOLD

Current Price

$355.28

Market Cap

141.2B

Sector

Health Care

ML Signal

HOLD

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

HOLD

Current Price

$54.65

Market Cap

111.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYK
BMY
Founded
1941
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.2B
111.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SYK
BMY
Price
$355.28
$54.65
Analyst Decision
Strong Buy
Buy
Analyst Count
15
13
Target Price
$432.13
$56.31
AVG Volume (30 Days)
1.7M
16.9M
Earning Date
01-27-2026
02-05-2026
Dividend Yield
0.99%
4.64%
EPS Growth
N/A
N/A
EPS
7.61
2.97
Revenue
$24,381,000,000.00
$48,034,000,000.00
Revenue This Year
$11.98
$0.23
Revenue Next Year
$8.60
N/A
P/E Ratio
$46.62
$18.27
Revenue Growth
10.95
1.26
52 Week Low
$329.16
$42.52
52 Week High
$406.19
$63.33

Technical Indicators

Market Signals
Indicator
SYK
BMY
Relative Strength Index (RSI) 43.50 69.74
Support Level $349.55 $54.01
Resistance Level $359.81 $54.86
Average True Range (ATR) 6.01 1.07
MACD 0.17 0.10
Stochastic Oscillator 35.65 96.91

Price Performance

Historical Comparison
SYK
BMY

About SYK Stryker Corporation

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

About BMY Bristol-Myers Squibb Company

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: